SCHEMBL5797843

SCHEMBL5797843

O=c1[nH]nc(CS(=O)(=O)Cl)[nH]1.O=c1[nH]nc(CSCc2ccccc2)[nH]1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 1/20 0.54
▸ LMNA P02545 2/20 0.45
▸ NPC1 O15118 1/20 0.42
▸ RAB9A P51151 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ ALDH1A1 P00352 2/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ DAO P14920 5/20 0.39
▸ MMP13 P45452 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ GLA P06280 1/20 0.36
▸ AKR1B1 P15121 1/20 0.36
▸ APOBEC3G Q9HC16 1/20 0.35
▸ MMP2 P08253 1/20 0.34
▸ MMP3 P08254 1/20 0.34
▸ MMP10 P09238 1/20 0.34
▸ MMP8 P22894 1/20 0.34
▸ MMP12 P39900 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ BTK Q06187 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4049551 0.87 TSHR (0.63) TSHRLMNANPC1RAB9ASMN1; SMN2
SCHEMBL4045604 0.78 GLA (0.47) TSHRGLA
SCHEMBL4054011 0.75 LMNA (0.51) TSHRLMNANPC1RAB9ASMN1; SMN2
SCHEMBL4046751 0.72 DAO (0.52) TSHRLMNANPC1RAB9ASMN1; SMN2
SCHEMBL29125694 0.72 RAB9A (0.51) TSHRLMNANPC1RAB9ASMN1; SMN2
SCHEMBL4047450 0.69 DAO (0.47) SMN1; SMN2DAOKMT2AHSD17B10
SCHEMBL5798854 0.68 ALDH1A1 (0.34) TSHRLMNASMN1; SMN2ALDH1A1CYP2C19
SCHEMBL12474423 0.68 DAO (0.73) TSHRLMNANPC1RAB9AALDH1A1
SCHEMBL29125953 0.66 TSHR (0.54) TSHRLMNAALDH1A1MMP13KMT2A
SCHEMBL29125771 0.66 KMT2A (0.54) TSHRLMNANPC1SMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1732903-A1 TRIAZOLONE DERIVATIVES AS MMP INHIBITORS FOR THE TREATMENT OF ASTHMA AND COPD AstraZeneca AB (SE) 2006-12-20 — — EP disclosed
WO-2005095362-A1 TRIAZOLONE DERIVATIVES AS MMP INHIBITORS FOR THE TREATMENT OF ASTHMA AND COPD ASTRAZENECA AB (SE) 2005-10-13 — — WO disclosed
Send feedback